Nausea, vomiting, and digestive discomfort are among the most common GLP-1 side effects. Here’s why Ozempic and Victoza affect digestion differently — and why some patients tolerate one medication better than the other.
Victoza is widely used for type 2 diabetes, but many patients also experience weight loss during treatment. Learn how liraglutide affects appetite, digestion, and metabolic health — plus the side effects and safety warnings patients should understand.
Rapid GLP-1 weight loss may improve metabolic health but accelerate facial aging. Experts explain how facial fat pad collapse and delayed collagen remodeling contribute to “Ozempic face.”
GLP-1 medications like Wegovy, Ozempic, and Mounjaro commonly cause nausea, bloating, and vomiting during early treatment. Here’s why these symptoms happen, when they become concerning, and the evidence-based strategies clinicians use to help patients stay on therapy.
Ozempic, Wegovy, and Saxenda can all contribute to gallbladder complications during rapid weight loss. Here’s how GLP-1 medications affect bile flow, gallstone formation, and digestive health.
Ozempic, Wegovy, and Saxenda can all contribute to gallbladder complications during rapid weight loss. Here’s how GLP-1 medications affect bile flow, gallstone formation, and digestive health.
Saxenda can support meaningful weight loss, but rapid fat reduction and altered bile flow may increase the risk of gallstones. Here’s what patients and clinicians should know about GLP-1 medications and gallbladder health.
GLP-1 medications such as semaglutide and tirzepatide may help patients with chronic kidney disease lose weight and improve metabolic health. But nephrologists warn that dehydration and gastrointestinal side effects can increase the risk of acute kidney injury in vulnerable patients.
Many patients report exhaustion, dizziness, and low energy during the first 24 to 48 hours after their weekly Mounjaro injection. This article explores how dehydration, reduced calorie intake, digestive slowing, and heart rate changes may contribute to “crash day” symptoms.
Fatigue is a common but often misunderstood side effect of Mounjaro (tirzepatide). This article explains how dehydration, reduced calorie intake, slowed digestion, and heart rate changes may contribute to low energy during treatment.